Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing
The essence of precision medicine is to achieve the goal of "individualized treatment" through genotyping of patients and targeted therapy. At present, the pathogenic genes of non-small cell lung cancer (NSCLC) have been studied most thoroughly and targeted therapy based on genotyping has...
Saved in:
Main Authors: | Jingsi Dong (Author), Bingjie Li (Author), Dan Lin (Author), Qinghua Zhou (Author), Depei Huang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular clusters reveal opportunities for personalised small cell lung cancer immunotherapy
by: Longjin Zeng, et al.
Published: (2022) -
Immunotherapy for a POLE Mutation Advanced Non-Small-Cell Lung Cancer Patient
by: Yang Fu, et al.
Published: (2022) -
Potential predictors of immunotherapy in small cell lung cancer
by: Valeria Skopelidou, et al.
Published: (2023) -
A network meta-analysis of immunotherapy-based treatments for advanced nonsquamous non-small cell lung cancer
by: Himani Aggarwal, et al.
Published: (2023) -
Current status of immunotherapy for non-small cell lung cancer
by: Tao Yang, et al.
Published: (2022)